199 related articles for article (PubMed ID: 25653517)
1. Specific targeting of A54 homing peptide-functionalized dextran-g-poly(lactic-co-glycolic acid) micelles to tumor cells.
Situ JQ; Ye YQ; Zhu XL; Yu RS; You J; Yuan H; Hu FQ; Du YZ
Int J Nanomedicine; 2015; 10():665-75. PubMed ID: 25653517
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional SPIO/DOX-loaded A54 Homing Peptide Functionalized Dextran-g-PLGA Micelles for Tumor Therapy and MR Imaging.
Situ JQ; Wang XJ; Zhu XL; Xu XL; Kang XQ; Hu JB; Lu CY; Ying XY; Yu RS; You J; Du YZ
Sci Rep; 2016 Oct; 6():35910. PubMed ID: 27775017
[TBL] [Abstract][Full Text] [Related]
3. Sialic-Acid-Anchored Micelles: A Hierarchical Targeting Device for Enhanced Tumor Tissue Accumulation and Cellular Internalization.
Zhu ML; Xu XL; Wang XJ; Zhang NN; Lu KJ; Qi J; Jin FY; Liu D; Du YZ
Mol Pharm; 2018 Sep; 15(9):4235-4246. PubMed ID: 30110551
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antitumor activity of stearate-g-dextran micelles for intracellular doxorubicin delivery.
Du YZ; Weng Q; Yuan H; Hu FQ
ACS Nano; 2010 Nov; 4(11):6894-902. PubMed ID: 20939508
[TBL] [Abstract][Full Text] [Related]
5. A54 Peptide Modified and Redox-Responsive Glucolipid Conjugate Micelles for Intracellular Delivery of Doxorubicin in Hepatocarcinoma Therapy.
Liu N; Tan Y; Hu Y; Meng T; Wen L; Liu J; Cheng B; Yuan H; Huang X; Hu F
ACS Appl Mater Interfaces; 2016 Dec; 8(48):33148-33156. PubMed ID: 27934140
[TBL] [Abstract][Full Text] [Related]
6. Tumor cells-specific targeting delivery achieved by A54 peptide functionalized polymeric micelles.
Du YZ; Cai LL; Liu P; You J; Yuan H; Hu FQ
Biomaterials; 2012 Dec; 33(34):8858-67. PubMed ID: 22959183
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin-incorporated polymeric micelles composed of dextran-b-poly(DL-lactide-co-glycolide) copolymer.
Jeong YI; Kim DH; Chung CW; Yoo JJ; Choi KH; Kim CH; Ha SH; Kang DH
Int J Nanomedicine; 2011; 6():1415-27. PubMed ID: 21796244
[TBL] [Abstract][Full Text] [Related]
8. High tolerated paclitaxel nano-formulation delivered by poly (lactic-co-glycolic acid)-g-dextran micelles to efficient cancer therapy.
Liu P; Situ JQ; Li WS; Shan CL; You J; Yuan H; Hu FQ; Du YZ
Nanomedicine; 2015 May; 11(4):855-66. PubMed ID: 25725489
[TBL] [Abstract][Full Text] [Related]
9. Poly[lactic-co-(glycolic acid)]-grafted hyaluronic acid copolymer micelle nanoparticles for target-specific delivery of doxorubicin.
Lee H; Ahn CH; Park TG
Macromol Biosci; 2009 Apr; 9(4):336-42. PubMed ID: 19006195
[TBL] [Abstract][Full Text] [Related]
10. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
Liu SQ; Tong YW; Yang YY
Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
[TBL] [Abstract][Full Text] [Related]
11. Folate receptor targeted biodegradable polymeric doxorubicin micelles.
Yoo HS; Park TG
J Control Release; 2004 Apr; 96(2):273-83. PubMed ID: 15081218
[TBL] [Abstract][Full Text] [Related]
12. Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin.
Zhang X; Li J; Yan M
Drug Dev Ind Pharm; 2016 Oct; 42(10):1590-9. PubMed ID: 26942448
[TBL] [Abstract][Full Text] [Related]
13. Self-assembled micelles based on Chondroitin sulfate/poly (d,l-lactideco-glycolide) block copolymers for doxorubicin delivery.
Zhang H; Xu J; Xing L; Ji J; Yu A; Zhai G
J Colloid Interface Sci; 2017 Apr; 492():101-111. PubMed ID: 28073063
[TBL] [Abstract][Full Text] [Related]
14. Self-assemblies of pH-activatable PEGylated multiarm poly(lactic acid-co-glycolic acid)-doxorubicin prodrugs with improved long-term antitumor efficacies.
Ding J; Li D; Zhuang X; Chen X
Macromol Biosci; 2013 Oct; 13(10):1300-7. PubMed ID: 23852836
[TBL] [Abstract][Full Text] [Related]
15. Self-assembled polymeric micelles based on hyaluronic acid-g-poly(D,L-lactide-co-glycolide) copolymer for tumor targeting.
Son GM; Kim HY; Ryu JH; Chu CW; Kang DH; Park SB; Jeong YI
Int J Mol Sci; 2014 Sep; 15(9):16057-68. PubMed ID: 25216338
[TBL] [Abstract][Full Text] [Related]
16. Improved therapeutic effect of DOX-PLGA-PEG micelles decorated with bivalent fragment HAb18 F(ab')(2) for hepatocellular carcinoma.
Jin C; Qian N; Zhao W; Yang W; Bai L; Wu H; Wang M; Song W; Dou K
Biomacromolecules; 2010 Sep; 11(9):2422-31. PubMed ID: 20831277
[TBL] [Abstract][Full Text] [Related]
17. TNYL peptide functional chitosan-g-stearate conjugate micelles for tumor specific targeting.
Chen FY; Yan JJ; Yi HX; Hu FQ; Du YZ; Yuan H; You J; Zhao MD
Int J Nanomedicine; 2014; 9():4597-608. PubMed ID: 25298734
[TBL] [Abstract][Full Text] [Related]
18. Development of novel self-assembled ES-PLGA hybrid nanoparticles for improving oral absorption of doxorubicin hydrochloride by P-gp inhibition: In vitro and in vivo evaluation.
Wang J; Li L; Wu L; Sun B; Du Y; Sun J; Wang Y; Fu Q; Zhang P; He Z
Eur J Pharm Sci; 2017 Mar; 99():185-192. PubMed ID: 27989702
[TBL] [Abstract][Full Text] [Related]
19. Redox-Responsive Amphipathic Dextran Nanomicelles for Solid Tumor Therapy.
Song Y; Lou B; Cheng J; Zhao P; Lin C; Wen X
J Biomed Nanotechnol; 2016 Dec; 12(12):2083-96. PubMed ID: 29368837
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin-loaded redox-responsive micelles based on dextran and indomethacin for resistant breast cancer.
Zhou Y; Wang S; Ying X; Wang Y; Geng P; Deng A; Yu Z
Int J Nanomedicine; 2017; 12():6153-6168. PubMed ID: 28883726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]